Denial, Not Money, Keeps Rural Indians From Oral Cancer Treatment

One of the most stubborn puzzles in global cancer control is why people who are screened, diagnosed, and offered free treatment still fail to show up for it. A new study from rural Assam in northeastern India has now put hard numbers on that puzzle, and the answer is not what many health planners expect. Researchers at the Cachar Cancer Hospital and Research Centre in Silchar followed more than two hundred people who had tested positive for oral precancerous lesions or oral cancer during community screening in the Katlicherra Health Block of Hailakandi District. Half of them had completed their treatment; half had walked away from it. When the team compared the two groups, they found essentially no difference in age, sex, income, or literacy. What separated the completers from the deferrers was not poverty or paperwork but something far harder to fix with a subsidy: the mind’s refusal to accept that a painless white patch or ulcer in the mouth could be cancer.

The study, published in BMC Cancer, was designed as a comparative cross-sectional investigation. The screening program itself had been funded by the Indian Council of Medical Research and run through the National Program for Prevention and Control of Non-Communicable Disease, with Accredited Social Health Activists, the village-level health workers known as ASHAs, identifying suspicious lesions using the Community-Based Assessment Checklist. Because treatment costs were covered, the program’s architects assumed that the main barrier to care had been removed. Yet a substantial fraction of screen-positive individuals still deferred follow-up and treatment. To understand why, the researchers used simple random sampling to select 107 individuals who had deferred treatment and 107 who had completed it within the same period, then administered a structured questionnaire by telephone or in person, collecting sociodemographic data and, for the deferrers, their stated reasons for not completing care.

The statistical analysis relied on chi-square tests for categorical comparisons and Mann-Whitney U tests for continuous variables, with significance set at a p-value below 0.05. The demographic comparison came back strikingly null. There were no significant differences between the deferred and completed-treatment groups in age, sex, annual income, or literacy. In other words, the classic socioeconomic explanations for treatment abandonment in low- and middle-income countries simply did not apply here. One trend did emerge: a higher proportion of confirmed cancers, as opposed to precancerous lesions, appeared in the deferred group, 22.6 percent versus 10.3 percent, a difference that approached but did not reach conventional significance at p equal to 0.073. That pattern is clinically alarming, because it suggests that the people most likely to walk away were also the ones carrying the most dangerous diagnoses.

The researchers then stratified the deferrers by the point at which they dropped out of the care pathway. Some had deferred at the subcenter level, the first point of contact in the rural health system, while others had made it all the way to the tertiary cancer center before abandoning treatment. Here the age effect was unmistakable. Patients who dropped out at the tertiary center were significantly older than those who deferred at the subcenter, and the proportion of older individuals was 29.6 percent in the tertiary-deferral group versus 7.5 percent among subcenter deferrers, a difference that was highly significant at p equal to 0.003. Older patients, it seems, face a distinct set of obstacles once they leave their villages: longer journeys, unfamiliar hospital environments, and perhaps a greater reluctance to undergo invasive treatment at an advanced stage of life.

The reasons patients gave for deferring treatment form the conceptual heart of the study. The single most frequently cited explanation, at both levels of the health system, was denial of symptoms. Among those who deferred at the subcenter, 58.5 percent said they simply did not accept that their symptoms mattered; among those who deferred at the tertiary center, 40.7 percent gave the same answer. The second most common reason was seeking treatment elsewhere, reported by 28.3 percent of subcenter deferrers and 38.9 percent of tertiary deferrers. Preference for alternative medicine came third, at 15.1 percent and 29.1 percent respectively, and family resistance accounted for 5.7 percent of subcenter deferrals and a striking 24.1 percent of tertiary deferrals. These are perceptual, cultural, and psychosocial barriers, and they dominated the data.

What is perhaps most remarkable is what did not appear in the responses. Logistical barriers such as travel costs, and purely financial obstacles such as the documents required to access support schemes, were reported by fewer than 2 percent of participants. For a population in one of the more remote corners of India, where the assumption in global health literature is that cost and distance are the dominant enemies of cancer care, this is a finding that demands a rethink. The financial safety net, in this program, worked. What failed was the conversation between the health system and the patient’s own understanding of disease. A lesion that does not hurt, does not bleed, and does not interfere with eating is easy to dismiss, particularly when acknowledging it means accepting a diagnosis that carries fear, stigma, and the prospect of surgery.

The psychology of denial in cancer screening is well documented in high-income settings, but its dominance in a rural South Asian cohort underscores how universal the mechanism is. Denial operates as a short-term coping strategy: by minimizing the threat, the patient avoids the anxiety of a cancer diagnosis, at least for a while. The tragedy is that oral cancer, when caught early as leukoplakia, erythroplakia, or an early-stage carcinoma, is highly treatable with excellent survival outcomes, whereas late-stage disease carries a dramatically worse prognosis. Every month of denial converts a curable lesion into a potentially lethal one. The finding that confirmed cancers were overrepresented among deferrers, even if the difference was only borderline significant, suggests exactly this dynamic was playing out in Hailakandi District: the patients with the most to lose were the ones most likely to look away.

The role of the family emerges as a second, underappreciated axis. Family resistance was cited by nearly a quarter of those who deferred at the tertiary level, a much higher figure than at the subcenter. In many rural Indian households, decisions about major medical interventions are collective, involving spouses, adult children, and elders. An older patient may be willing to travel to the cancer hospital, only to be talked out of surgery by relatives who fear the cost of lost labor, the burden of caregiving, or the perceived indignity of cancer treatment. The study’s authors argue that this pattern calls for family-inclusive counselling, in which the household, not just the individual, is brought into the clinical conversation. A consent process that ignores the family’s influence may be technically complete but practically powerless.

Preference for alternative medicine, cited by up to 29 percent of tertiary-level deferrers, represents another cultural fault line. Traditional and herbal remedies are deeply embedded in rural healthcare-seeking behavior across South Asia, and for a painless oral lesion they offer an apparently low-risk first option. The challenge for oncologists is not to dismiss these practices but to communicate that a precancerous lesion is a window of opportunity that alternative therapies cannot close. The study’s conclusions point toward three interventions: strengthening patient navigation so that a screen-positive individual is actively escorted through each step of the referral pathway, embedding family members in counselling sessions, and delivering targeted health literacy interventions that explain, in locally resonant terms, why a symptomless patch in the mouth demands immediate attention.

The broader lesson for cancer control in low- and middle-income countries is that screening without treatment completion is a half-measure, and that the barriers to completion are not always the ones that money can remove. Community-based screening programs, which have expanded across India under the national non-communicable disease program, generate a pipeline of screen-positive individuals whose outcomes depend entirely on what happens after the referral slip is handed over. This Assam study shows that even a well-funded program with free treatment, dedicated ASHA workers, and an accessible tertiary center can lose a large share of its patients to denial, alternative medicine, and family dynamics. Converting early detection into timely treatment, the authors conclude, requires the health system to treat perception as seriously as it treats pathology. In the fight against oral cancer in rural India, the next frontier is not the wallet but the mind, and closing that gap may do more to improve survival than any additional rupee spent on subsidies.

Subject of Research: Non-financial barriers to oral cancer treatment completion after community screening in rural Northeast India

Article Title: Non-financial barriers drive oral cancer treatment deferral despite free care in rural Northeast India

Article References: Goala, S., Sharma, P., Subramanian, V., Baul, G., Dey, J., Barlaskar, B. R., Singha, K., Kabui, J., Gadgil, A., & Kannan, R. (2026). Non-financial barriers drive oral cancer treatment deferral despite free care in rural Northeast India. BMC Cancer. https://doi.org/10.1186/s12885-026-16622-x

Image Credits: AI Generated

DOI: 10.1186/s12885-026-16622-x

Keywords: oral cancer, cancer screening, treatment deferral, rural India, health barriers, denial of symptoms, alternative medicine, patient navigation, health literacy, family counselling, Assam, preventive oncology